Showing papers on "SAIDS Vaccines published in 2017"

TL;DR: Xu et al. as discussed by the authors used a vaccine composed exclusively of SIVmac239 regulatory genes expressed as a single Tat-Vif-Rev-Vpr fusion protein coupled to an HLA class II domain.